ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625731 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625731; 2) Community: the network communities that were significantly associated with the response to NSC 625731; 3) Molecule: the relationships between components within communities and NSC 625731; 4) MDR: the compounds that were significantly associated with the NSC 625731.

NSC Compound Enrichment Correlation
NSC 626878 Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride 0.000166573147098352 0.50152768
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.000166573147098352 0.51815383
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.000166573147098354 0.25231423
NSC 329691 HM-4 0.000166573147098354 0.37500811
NSC 633041 Null 0.000184748296800011 0.46814776
NSC 700125 Null 0.000184748296800011 0.42461381
NSC 372950 Null 0.000192047964657655 0.24093388
NSC 720340 Null 0.000192047964657657 0.45765816
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.000192047964657657 0.37196964
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 0.000380874609232495 0.54036539
Total:89  Current:1    [First] [Prev] [Next] [Last]